General Guidance
|
This page contains a few different types of documents including: guidances, SOPs, and worksheets/checklists.
- Guidance documents are for researchers and their teams to better understand OIA's thinking or expectations on matters for which there isn't an SOP or clear regulatory directive.
- SOPs are for outlining how a process is to be completed. Most of the SOPs on this page are for OIA; however, SOPs for research teams are listed in the SOPs section as well.
- NOTE: The SOP section only lists those SOPs promulgated by OIA and should not be regarded as a complete listing of SOPs for researchers as UCSD may have other SOPs that are required.
- Worksheets and Checklists are for use by the IRBs and OIA staff. They do not need to be completed or submitted by researchers. They are posted here to allow researchers to better understand the criteria OIA staff and the IRBs use in making certain decisions and determinations.
Your feedback, questions and comments are always welcomed at IRB@ucsd.edu.
Quick Links
Guidances
These documents are for researchers and their teams to better understand OIA's thinking or expectations on matters for which there isn't an SOP or clear regulatory directive.
General
- NIH Definition of a Clinical Trial (PDF)
- Registration of Clinical Trials in a Public Registry (PDF)
- Registration of Clinical Trials in a Public Registry (PDF)
- Is this Human Subject Research? | Box Diagram (PDF)
IRB Review Process
- Simplified UCSD IRB Review Flowchart
- Detailed UCSD IRB Review Flowchart
Training
- Human Subject Protection Training | CITI (PDF)
HIPAA Research Privacy training is offered by the CITI Program and is now available to UCSD faculty and staff. This training will replace the legacy HIPAA training offered on OIA's old webpage which will be retired by August 2023.
For additional information on available CITI training and instructions for accessing the training modules, please see the Office of Compliance and Privacy’s pulse page: Collaborative Institutional Training Initiative (CITI) Program
Privacy & Confidentiality
- HIPAA Authorization Forms
- Protected Health Information (PHI) in Research (PDF)
- Deidentified Health Information (PDF)
- Certificate of Confidentiality | CoC (PDF)
- HIV Reporting & Research (PDF)
- Research Using Death Records (PDF)
Vulnerable Populations
Reliance
- SDSU Joint Protocol Review February 2024 (PDF)
Informed Consent
Drugs and Devices
Required Submissions
Research on Specific Medical Conditions
SOPs
These documents are for outlining how a process is to be completed. Most of the SOPs in this section are for OIA; however, SOPs for research teams are listed in this section as well.
Investigators
013 Legally Authorized Representatives, Children, and Guardians
090 Informed Consent Process for Research
091 Written Documentation of Consent
092 Assent Process for Research
093 Written Documentation of Assent
094 Human Research Internet Recruitment
103 IRB Handbook
Administrative Review
020 Incoming Items Directed to the Office of IRB Administration
021 Pre-Review
026 Suspension or Termination of IRB Approval
Non-Committee Review
031 Non-Committee Review Preparation
032 Non-Committee Review Conduct
063 Expiration of IRB Approval
Committee Review
042 IRB Meeting Attendance Monitoring
Review Addenda
052 Post-Review
055 Financial Conflicts of Interest
Reliances and sIRBs
058 UCSD Relying on an External IRB
059 UCSD Serving as the IRB of Record
085 Establishing Reliance Agreements
OIA Operations
001 Definitions
012 Observation of the Consent Process
071 Standard Operating Procedures
Previous SOPPs and SOPs
Previous SOPPs/SOPs which are no longer in effect but may still be needed by researchers to aid in audits by Sponsors or Regulatory Agencies can be found on our Previous SOPPs/SOPs webpage.
Worksheets and Checklists
These documents are generally for use by the IRBs and OIA staff; however, researchers may find them useful for understanding what OIA and the IRBs consider when making decisions and determinations. They do not need to be completed or submitted by researchers.
Worksheets
301 Review Materials
302 Calculation of Approval Intervals
303 Communication of Review Results
304 IRB Composition
305 Evaluation of Quorum and Expertise
306 Drugs
307 Devices
308 Admin Pre-Review
310 Human Research Determination
313 Eligibility for Review Using the Expedited Procedure
314 Criteria for Approval and Additional Considerations
314B Requirements for Informed Consent
315 Advertisements
316 Payments
317 Short Form of Consent Documentation
318 Additional Federal Criteria
319 Approval Period
320 Scientific or Scholarly Review
321 Review of Reportable Events
322 Emergency Use
323 Criteria and Additional Considerations HUD
335 Minutes Quality Improvement Assessment
Checklists
401 Pre-Review
410 Waiver or Alteration of the Consent Process
411 Waiver of Written Documentation of Consent
414 Neonates of Uncertain Viability
415 Prisoners
416 Children
417 Cognitively Impaired Adults
418 Non-Significant Risk Device
419 Waiver of the Consent Process for Emergency Research
441 HIPAA Waiver of Authorization